Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreo Medical Regulatory News (CREO)

Share Price Information for Creo Medical (CREO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 35.25
Bid: 35.00
Ask: 35.50
Change: -0.50 (-1.40%)
Spread: 0.50 (1.429%)
Open: 35.75
High: 35.75
Low: 35.25
Prev. Close: 35.75
CREO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notifiable interest in securities

3 Apr 2009 13:24

RNS Number : 1163Q
China Real Estate Opportunities PLC
03 April 2009
 



3 April 2009

China Real Estate Opportunities plc 

Notifiable interest in securities 

The Board of China Real Estate Opportunities plc ("CREO" or the "Company") announces that on 2 April 2009, the Company was notified by Treasury Holdings (which is owned as to 50 per cent. by Richard Barrett, a director and significant shareholder of the Company, and as to 50 per cent. by John Ronan, a significant shareholder of the Company) that the following transactions have been undertaken in the ordinary shares of the Company. 

Treasury Holdings has disposed of 661,000 ordinary shares to Treasury Properties Limited. 

Treasury Holdings has disposed of 2,000,000 ordinary shares to Jasbay Properties Limited.

420,653 ordinary shares held by Treasury Holdings in trust for Treasury Holdings China Limited have been transferred to Treasury Holdings China Limited.

Treasury Holdings China Limited has disposed of 420,653 ordinary shares to Treasury Properties Limited.

In addition the Company was notified on 2 April 2009 by Real Estate Opportunities Limited that they have disposed of 8,387,941 ordinary shares, in equal amounts, to four wholly owned subsidiaries being Real Estate Opportunities Holdings Limited, REO (CREO Holdings) No.1 Limited, REO (CREO Holdings) No.2 Limited and REO (CREO Holdings) No.3 Limited. 

All the above transactions were undertaken at a price of £2.175 per ordinary share.

There is no change in the ultimate beneficial ownership of these ordinary shares. The Concert Party (as defined in the Notice of Extraordinary General Meeting) remain interested in 25,973,984 ordinary shares, representing 54.96 per cent of the Company's issued share capital. 

Contact: 

CREO 

Ray Horney, Chairman 

Tel: + 44 (0) 1273 775 225 

 

Sarah Moriarty, Investor Relations 

Tel: + 353 1 618 9455 

Matrix Corporate Capital LLP 

Paul Fincham, Rob Naylor 

Tel: + 44 (0) 20 3206 7000 

Davy 

Des Carville 

Tel: + 353 1 679 6363 

Bankside Consultants 

Simon Rothschild, Oliver Winters 

Tel: + 44 (0) 20 7367 8888 

Murray Consultants 

Ed Micheau 

Tel: + 353 1 498 0300

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUOUURKURSRAR
Date   Source Headline
21st Feb 202310:29 amRNSHolding(s) in Company
17th Feb 20232:05 pmRNSSecond Price Monitoring Extn
17th Feb 20232:00 pmRNSPrice Monitoring Extension
17th Feb 202312:10 pmRNSLaunch of Open Offer and Posting of Circular
16th Feb 20236:04 pmRNSResult of Placing and Subscription
16th Feb 20239:05 amRNSSecond Price Monitoring Extn
16th Feb 20239:00 amRNSPrice Monitoring Extension
16th Feb 20237:00 amRNSPlacing and Subscription to raise a minimum £25m
15th Feb 202311:05 amRNSSecond Price Monitoring Extn
15th Feb 202311:00 amRNSPrice Monitoring Extension
30th Jan 20238:51 amRNSAward of Shares under Share Incentive Plan
23rd Jan 202311:47 amEQSCreo Medical (CREO): Progressing on all fronts
18th Jan 20232:05 pmRNSSecond Price Monitoring Extn
18th Jan 20232:00 pmRNSPrice Monitoring Extension
11th Jan 20237:00 amRNSFY 2022 Trading Update
16th Dec 20222:05 pmRNSSecond Price Monitoring Extn
16th Dec 20222:00 pmRNSPrice Monitoring Extension
1st Dec 20222:12 pmRNSHolding(s) in Company
24th Oct 20227:00 amRNSKamaptive Licence and Royalty Agreement with CMR
30th Sep 20227:00 amRNSTotal Voting Rights
23rd Sep 20227:00 amRNSExercise of Options
23rd Sep 20227:00 amRNSExercise of Options
22nd Sep 20227:00 amRNSChris Hancock elected as a Fellow of Royal Academy
9th Sep 20227:00 amRNSHalf-year Report
5th Sep 20227:00 amRNSNotice of Results
31st Aug 20227:00 amRNSTotal Voting Rights
8th Aug 20227:00 amRNSLTIP Awards and PDMR Dealing
4th Aug 20227:00 amRNSExercise of Options
3rd Aug 20227:00 amRNSH1 2022 Trading Update
2nd Aug 20227:00 amRNSAward of Shares under Share Incentive Plan
28th Jun 202212:33 pmRNSResult of AGM
28th Jun 20227:00 amRNSAGM Statement
27th May 20227:00 amRNSDirector/PDMR Shareholding
26th May 20227:00 amRNSPosting of 2021 Annual Report and Accounts
23rd May 20227:01 amRNSFinal Results
23rd May 20227:00 amRNSCollaboration agreement with Intuitive
18th May 20223:22 pmRNSHolding(s) in Company
17th May 20227:00 amRNSNotice of Results
28th Apr 20227:00 amRNSTrading update and notice of results
20th Apr 20227:00 amRNSOpening of Singapore regional hub
5th Apr 20227:00 amRNSCTO wins Technology Innovator of the Year Award
16th Mar 20227:00 amRNSAlbyn Medical earn out update
28th Feb 20227:00 amRNSTotal Voting Rights
7th Feb 20227:00 amRNSPresentation at Growth and Innovation Forum 2022
4th Feb 20227:00 amRNSAward of Shares under Share Incentive Plan
3rd Feb 20224:41 pmRNSSecond Price Monitoring Extn
3rd Feb 20224:35 pmRNSPrice Monitoring Extension
3rd Feb 20227:00 amRNSTrading update
24th Jan 20227:00 amRNSLicensing & Partnership update
31st Dec 20217:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.